Microsoft Stock Under Pressure: Copilot Health Waitlist Opens

Microsoft shares (NASDAQ:MSFT) have traded in a narrow range around $404 through much of this month, marking a sharp reversal from the stock’s previous momentum. The YTD decline has wiped out over $400 billion in market cap, with MSFT in it’s own bear market, down 0.38% today, and more than 25% off October’s high, less than six months ago.

The company has today opened a waitlist for Copilot Health, a dedicated AI-powered health assistant, as the company looks to shift momentum.

Microsoft’s latest product announcement centres on Copilot Health, described as a “separate, secure space within Copilot where medical intelligence makes sense of your information and delivers personalised health insights that you can act on.” The platform aims to aggregate health records, wearable device data, and health history into a unified interface, applying artificial intelligence to identify patterns and connections that might otherwise go unnoticed.

According to the company’s announcement, Copilot Health is designed to help users understand relationships between symptoms and underlying causes, such as connecting broken sleep patterns to their root drivers. The goal is to move users away from late-night symptom searches and toward more informed conversations with healthcare providers.

Microsoft is taking a measured approach to the rollout, launching with a phased deployment strategy. The company has opened a waitlist for early adopters who will help shape the product experience before a broader public launch. This cautious approach reflects the heightened regulatory, privacy, and liability considerations inherent in healthcare technology, where accuracy and data security carry significant consequences.

The healthcare focus aligns with emerging user behaviour patterns. Microsoft’s AI leadership has previously indicated that health-related questions represent the top topic for Copilot mobile queries, particularly during evening hours, suggesting genuine product-market fit for a dedicated health-focused offering.

Fundamental Picture

The Copilot Health announcement comes against a backdrop of exceptional financial performance that has nonetheless failed to satisfy markets focused on the sustainability of AI-driven growth. Microsoft’s most recent quarter, covering October through December 2025, delivered approximately $81.3 billion in revenue, representing year-over-year growth of roughly 16-17%. The quarter also marked the most profitable in company history, with net income reaching $38.5 billion and operating margins hovering near 47%.

Microsoft Cloud revenue continues to drive overall performance, with AI-enhanced workloads contributing meaningfully to growth rates that remain well above broader market averages. The company’s ability to maintain best-in-class margins while simultaneously ramping artificial intelligence infrastructure investments distinguishes it from peers facing similar capital intensity challenges.

However, markets have grown increasingly focused on the denominator rather than the numerator. Microsoft’s capital expenditure related to AI infrastructure, including data centres, graphics processing units, and networking equipment, now represents over a third of revenue. This investment trajectory has raised questions about how long the company can sustain such spending levels and when returns on these investments will fully materialise in the income statement.

The Software Slump of 2026

Microsoft’s decline has unfolded within a broader sector downturn that market observers have dubbed the “software slump of 2026.” Major technology names including Amazon, Meta Platforms, and Alphabet have all posted negative year-to-date returns, with many software-focused companies experiencing drawdowns of 10-20% or more. The selloff reflects a factor rotation away from richly valued growth stocks, exacerbated by concerns about long-duration cash flows in an environment of elevated or sticky long-term interest rates.

The post-earnings selloff in late January crystallised the shift in market sentiment. Despite delivering results that exceeded analyst expectations across revenue, earnings per share, and cloud growth metrics, Microsoft experienced what some commentators described as a textbook “sell the news” reaction. The episode highlighted that expectations, rather than fundamentals, had become the primary driver of near-term price action.

The technology sector’s underperformance has been particularly pronounced among AI-heavy names, where years of concentrated inflows into megacap technology stocks have created potential crowding risk. Some portfolio managers have begun reducing overweight positions in the largest AI beneficiaries, seeking diversification into other sectors or smaller capitalisation opportunities.

Valuation Reset Creates Long-Term Opportunity

For fundamental analysts focused on multi-year time horizons, the valuation compression has created what many view as a rare opportunity to acquire shares of a best-in-class compounder at a relative discount. Detailed valuation work suggests that Microsoft’s current multiple sits materially below the premium historically assigned to companies with comparable growth rates, profitability, and competitive positioning.

The company’s ability to generate robust free cash flow while investing heavily in next-generation infrastructure provides a cushion that many competitors lack. Operating margins in the high-40s make Microsoft an outlier, demonstrating that the company can both invest aggressively and maintain exceptional profitability. This dynamic supports the thesis that Microsoft could eventually moderate capital expenditure growth while preserving a high earnings base, creating significant operating leverage as AI monetisation matures.

The Copilot Health initiative represents a strategic expansion beyond Microsoft’s traditional enterprise-focused AI offerings. While Copilot for Microsoft 365 and GitHub Copilot target workplace productivity, Copilot Health addresses a consumer-facing use case with potentially different monetisation dynamics and regulatory requirements.

The healthcare vertical offers several attractive characteristics for platform builders. Willingness to pay for health-related services tends to be high, societal impact is significant, and successful integration of health data creates powerful lock-in effects. If Microsoft can navigate the regulatory landscape and build trust with users and healthcare providers, the initiative could open optionality for premium features, care navigation tools, and integration with insurers and provider networks.

However, the timing of the announcement has drawn mixed reactions. Markets currently rewarding near-term monetisation and capital discipline may view Copilot Health as another AI experiment that adds complexity and spending before contributing meaningfully to earnings. The initiative also introduces heightened regulatory and reputational risk, as any privacy breach or inaccurate medical guidance could trigger significant scrutiny at a time when big technology companies’ AI deployments already face intense examination.

Microsoft’s launch of Copilot Health demonstrates the company’s commitment to expanding its AI platform into high-value verticals, but the initiative arrives at a moment when markets are reassessing the entire AI investment thesis rather than rewarding new product announcements. With fundamentals remaining strong but sentiment depressed, the stock sits at a crossroads where long-term value investors see opportunity while momentum-focused traders remain cautious about catching a falling knife in a sector still searching for a bottom.